JT
TEVA icon

Jump Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Jump Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,300
Closed -$266K – 512
2016
Q2 		$266K Buy
5,300
+5,214
+6,063% +$278K 0.01% 558
2016
Q1 		$460K Sell
86
-85
-50% -$4.99K 0.02% 352
2015
Q4 		$1.12M Sell
171
-307
-64% -$19K 0.04% 232
2015
Q3 		$2.55M Sell
478
-322
-40% -$20.9K 0.03% 90
2015
Q2 		$47K Sell
800
-5,300
-87% -$327K ﹤0.01% 970
2015
Q1 		$380K Sell
6,100
-1,500
-20% -$87.2K 0.01% 470
2014
Q4 		$438K Buy
7,600
+4,500
+145% +$251K 0.01% 496
2014
Q3 		$167K Buy
+3,100
New +$164K 0.01% 664

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Trading's TEVA Position: Q2 2020 in Review

Jump Trading sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 14,915 shares — an estimated $134K sold.

Jump Trading first reported a position in TEVA in Q3 2014 and held it in 6 quarters. The position peaked at $692K in Q3 2015. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Jump Trading reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Jump Trading sold 14,915 Teva Pharmaceuticals shares in Q2 2020, an estimated $134K.
  • Jump Trading first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Jump Trading's Teva Pharmaceuticals position peaked at $692K in Q3 2015.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.